WHO Sounds Warning Over Severe Lack of Weight-Loss Jabs

Under one in 10 patients eligible to benefit from GLP-1 drugs like Wegovy are able to get them, states the global health agency as it publishes its inaugural guidance on the therapies.

Given in excess of 1,000,000,000 individuals worldwide now classified as obese, it is calling for broader and more equitable access to GLP-1 medication.

Per projections, over two billion could be living with obesity by 2030 if no action is taken.

"The latest guidance acknowledges that excess weight is a long-term condition that can be treated with holistic and continuous treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and supply-chain constraints are major obstacles to widespread access to the jabs that can help people shift considerable body mass, explains the organization.

GLP-1 Therapy Scarcity

Even in the current most optimistic case, the manufacturing of these medications might only reach approximately 100 million people – under 10% of those who need them, as stated by the health organization.

The advice urges countries and companies to expand availability, through measures including licensing agreements.

The intellectual property rights on the active ingredient – the main ingredient of a leading brand – is due to expire in a number of nations in 2026.

How Obesity Drugs Operate

The injections imitate a biological compound to delay gastric emptying, suppress the appetite and boost the sense of being full so people eat less.

Individuals commonly begin shedding pounds in the initial weeks of commencing the once-weekly jabs.

Evidence indicates people may regain a significant portion within a year of stopping the drug, because their normal hunger return.

To be above a healthy weight raises your likelihood for contracting medical conditions, including type 2 diabetes, heart disease, brain attack, and certain malignancies.

Excess weight concerns individuals in all nations and was associated with millions of fatalities worldwide in 2024, per the WHO.